APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dementia and Alzheimer’s Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dementia and Alzheimer’s Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026199 pages

Choose your research edition.

Industry ResearchDementia and Alzheimer’s Disease Treatment Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Dementia and Alzheimer’s Disease Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Dementia and Alzheimer’s Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dementia and Alzheimer’s Disease Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Dementia and Alzheimer’s Disease Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Dementia and Alzheimer’s Disease Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Dementia and Alzheimer’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dementia and Alzheimer’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dementia and Alzheimer’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dementia and Alzheimer’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dementia and Alzheimer’s Disease Treatment include Novartis, Eli Lilly and Company, Pfizer, Inc., AbbVie Inc., AstraZeneca, INmuneBIO, F. Hoffmann-La Roche Ltd., Eisai Co., Ltd. and Biogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Dementia and Alzheimer’s Disease Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dementia and Alzheimer’s Disease Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dementia and Alzheimer’s Disease Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Dementia and Alzheimer’s Disease Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Dementia and Alzheimer’s Disease Treatment Segment by Company

Novartis

Eli Lilly and Company

Pfizer, Inc.

AbbVie Inc.

AstraZeneca

INmuneBIO

F. Hoffmann-La Roche Ltd.

Eisai Co., Ltd.

Biogen

Allergan plc

Dementia and Alzheimer’s Disease Treatment Segment by Type

Combination Drugs

Memantine

Cholinesterase Inhibitors

Dementia and Alzheimer’s Disease Treatment Segment by Application

Hospital

Clinic

Dementia and Alzheimer’s Disease Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dementia and Alzheimer’s Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dementia and Alzheimer’s Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dementia and Alzheimer’s Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Dementia and Alzheimer’s Disease Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dementia and Alzheimer’s Disease Treatment industry.

Chapter 3: Detailed analysis of Dementia and Alzheimer’s Disease Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dementia and Alzheimer’s Disease Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Combination Drugs Table 3. Key Players of Memantine Table 4. Key Players of Cholinesterase Inhibitors Table 4. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region (2021-2026) Table 10. Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region (2027-2032) Table 12. Dementia and Alzheimer’s Disease Treatment Industry Trends Table 13. Dementia and Alzheimer’s Disease Treatment Industry Drivers Table 14. Dementia and Alzheimer’s Disease Treatment Industry Opportunities and Challenges Table 15. Dementia and Alzheimer’s Disease Treatment Industry Restraints Table 16. Global Dementia and Alzheimer’s Disease Treatment Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Company (2021-2026) Table 18. Global Dementia and Alzheimer’s Disease Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Dementia and Alzheimer’s Disease Treatment Key Company Head Office and Area Served Table 20. Global Dementia and Alzheimer’s Disease Treatment Company, Product Type & Application Table 21. Global Dementia and Alzheimer’s Disease Treatment Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Dementia and Alzheimer’s Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Dementia and Alzheimer’s Disease Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2021-2026) Table 28. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2027-2032) Table 29. Global Dementia and Alzheimer’s Disease Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Dementia and Alzheimer’s Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2021-2026) Table 33. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2027-2032) Table 34. Novartis Company Information Table 35. Novartis Business Overview Table 36. Novartis Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Novartis Dementia and Alzheimer’s Disease Treatment Product Portfolio Table 38. Novartis Recent Development Table 39. Eli Lilly and Company Company Information Table 40. Eli Lilly and Company Business Overview Table 41. Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product Portfolio Table 43. Eli Lilly and Company Recent Development Table 44. Pfizer, Inc. Company Information Table 45. Pfizer, Inc. Business Overview Table 46. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product Portfolio Table 48. Pfizer, Inc. Recent Development Table 49. AbbVie Inc. Company Information Table 50. AbbVie Inc. Business Overview Table 51. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product Portfolio Table 53. AbbVie Inc. Recent Development Table 54. AstraZeneca Company Information Table 55. AstraZeneca Business Overview Table 56. AstraZeneca Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. AstraZeneca Dementia and Alzheimer’s Disease Treatment Product Portfolio Table 58. AstraZeneca Recent Development Table 59. INmuneBIO Company Information Table 60. INmuneBIO Business Overview Table 61. INmuneBIO Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. INmuneBIO Dementia and Alzheimer’s Disease Treatment Product Portfolio Table 63. INmuneBIO Recent Development Table 64. F. Hoffmann-La Roche Ltd. Company Information Table 65. F. Hoffmann-La Roche Ltd. Business Overview Table 66. F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product Portfolio Table 68. F. Hoffmann-La Roche Ltd. Recent Development Table 69. Eisai Co., Ltd. Company Information Table 70. Eisai Co., Ltd. Business Overview Table 71. Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product Portfolio Table 73. Eisai Co., Ltd. Recent Development Table 74. Biogen Company Information Table 75. Biogen Business Overview Table 76. Biogen Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Biogen Dementia and Alzheimer’s Disease Treatment Product Portfolio Table 78. Biogen Recent Development Table 79. Allergan plc Company Information Table 80. Allergan plc Business Overview Table 81. Allergan plc Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Allergan plc Dementia and Alzheimer’s Disease Treatment Product Portfolio Table 83. Allergan plc Recent Development Table 84. North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 85. North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 86. North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 87. North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 88. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026) Table 90. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2027-2032) Table 91. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 92. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 93. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 94. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 95. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026) Table 97. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2027-2032) Table 98. China Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 99. China Dementia and Alzheimer’s Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 100. China Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 101. China Dementia and Alzheimer’s Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 103. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 104. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 105. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 106. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026) Table 108. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Country (2027-2032) Table 109. South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 110. South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 111. South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026) Table 115. South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Dementia and Alzheimer’s Disease Treatment Product Image Figure 2. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Dementia and Alzheimer’s Disease Treatment Market Share by Type: 2025 VS 2032 Figure 4. Combination Drugs Image Figure 5. Memantine Image Figure 6. Cholinesterase Inhibitors Image Figure 7. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Dementia and Alzheimer’s Disease Treatment Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Global Dementia and Alzheimer’s Disease Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 13. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Dementia and Alzheimer’s Disease Treatment Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2021-2032) Figure 22. North America Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 23. North America Dementia and Alzheimer’s Disease Treatment Market Share by Type (2021-2032) Figure 24. North America Dementia and Alzheimer’s Disease Treatment Market Share by Application (2021-2032) Figure 25. North America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2021-2032) Figure 26. United States Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 27. Canada Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Europe Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Type (2021-2032) Figure 31. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Application (2021-2032) Figure 32. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Country (2021-2032) Figure 33. Germany Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 34. France Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 36. Italy Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Russia Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 39. China Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Dementia and Alzheimer’s Disease Treatment Market Share by Type (2021-2032) Figure 41. China Dementia and Alzheimer’s Disease Treatment Market Share by Application (2021-2032) Figure 42. Asia Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 43. Asia Dementia and Alzheimer’s Disease Treatment Market Share by Type (2021-2032) Figure 44. Asia Dementia and Alzheimer’s Disease Treatment Market Share by Application (2021-2032) Figure 45. Asia Dementia and Alzheimer’s Disease Treatment Market Share by Country (2021-2032) Figure 46. Japan Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 50. India Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Australia Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Country (2021-2032) Figure 56. Brazil Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 61. UAE Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Chile Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Combination Drugs
  • Memantine
  • Cholinesterase Inhibitors
Applications
  • Hospital
  • Clinic
Companies covered
  • Novartis
  • Eli Lilly and Company
  • Pfizer, Inc.
  • AbbVie Inc.
  • AstraZeneca
  • INmuneBIO
  • F. Hoffmann-La Roche Ltd.
  • Eisai Co., Ltd.
  • Biogen
  • Allergan plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Combination Drugs
  5. 1.2.3 Memantine
  6. 1.2.4 Cholinesterase Inhibitors
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Dementia and Alzheimer’s Disease Treatment Growth Trends by Region
  13. 1.5.1 Global Dementia and Alzheimer’s Disease Treatment Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Dementia and Alzheimer’s Disease Treatment Market Size by Region (2021-2026)
  15. 1.5.3 Dementia and Alzheimer’s Disease Treatment Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Dementia and Alzheimer’s Disease Treatment Market Dynamics
  1. 2.1 Dementia and Alzheimer’s Disease Treatment Industry Trends
  2. 2.2 Dementia and Alzheimer’s Disease Treatment Industry Drivers
  3. 2.3 Dementia and Alzheimer’s Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Dementia and Alzheimer’s Disease Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Dementia and Alzheimer’s Disease Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Dementia and Alzheimer’s Disease Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Dementia and Alzheimer’s Disease Treatment Key Company Head office and Area Served
  4. 3.4 Global Dementia and Alzheimer’s Disease Treatment Company, Product Type & Application
  5. 3.5 Global Dementia and Alzheimer’s Disease Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Dementia and Alzheimer’s Disease Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Dementia and Alzheimer’s Disease Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Dementia and Alzheimer’s Disease Treatment Tier 1, Tier 2, and Tier 3
4 Dementia and Alzheimer’s Disease Treatment Market by Type
  1. 4.1 Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Dementia and Alzheimer’s Disease Treatment Market Size Share by Type (2021-2032)
5 Dementia and Alzheimer’s Disease Treatment Market by Application
  1. 5.1 Global Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Dementia and Alzheimer’s Disease Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Dementia and Alzheimer’s Disease Treatment Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Eli Lilly and Company
  8. 6.2.1 Eli Lilly and Company Company Information
  9. 6.2.2 Eli Lilly and Company Business Overview
  10. 6.2.3 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product Portfolio
  12. 6.2.5 Eli Lilly and Company Recent Developments
  13. 6.3 Pfizer, Inc.
  14. 6.3.1 Pfizer, Inc. Company Information
  15. 6.3.2 Pfizer, Inc. Business Overview
  16. 6.3.3 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product Portfolio
  18. 6.3.5 Pfizer, Inc. Recent Developments
  19. 6.4 AbbVie Inc.
  20. 6.4.1 AbbVie Inc. Company Information
  21. 6.4.2 AbbVie Inc. Business Overview
  22. 6.4.3 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product Portfolio
  24. 6.4.5 AbbVie Inc. Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AstraZeneca Dementia and Alzheimer’s Disease Treatment Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 INmuneBIO
  32. 6.6.1 INmuneBIO Company Information
  33. 6.6.2 INmuneBIO Business Overview
  34. 6.6.3 INmuneBIO Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 INmuneBIO Dementia and Alzheimer’s Disease Treatment Product Portfolio
  36. 6.6.5 INmuneBIO Recent Developments
  37. 6.7 F. Hoffmann-La Roche Ltd.
  38. 6.7.1 F. Hoffmann-La Roche Ltd. Company Information
  39. 6.7.2 F. Hoffmann-La Roche Ltd. Business Overview
  40. 6.7.3 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product Portfolio
  42. 6.7.5 F. Hoffmann-La Roche Ltd. Recent Developments
  43. 6.8 Eisai Co., Ltd.
  44. 6.8.1 Eisai Co., Ltd. Company Information
  45. 6.8.2 Eisai Co., Ltd. Business Overview
  46. 6.8.3 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product Portfolio
  48. 6.8.5 Eisai Co., Ltd. Recent Developments
  49. 6.9 Biogen
  50. 6.9.1 Biogen Company Information
  51. 6.9.2 Biogen Business Overview
  52. 6.9.3 Biogen Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Biogen Dementia and Alzheimer’s Disease Treatment Product Portfolio
  54. 6.9.5 Biogen Recent Developments
  55. 6.10 Allergan plc
  56. 6.10.1 Allergan plc Company Information
  57. 6.10.2 Allergan plc Business Overview
  58. 6.10.3 Allergan plc Dementia and Alzheimer’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Allergan plc Dementia and Alzheimer’s Disease Treatment Product Portfolio
  60. 6.10.5 Allergan plc Recent Developments
7 North America
  1. 7.1 North America Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032)
  2. 7.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type
  3. 7.2.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Dementia and Alzheimer’s Disease Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application
  7. 7.3.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Dementia and Alzheimer’s Disease Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country
  11. 7.4.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032)
  2. 8.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type
  3. 8.2.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Dementia and Alzheimer’s Disease Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application
  7. 8.3.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Dementia and Alzheimer’s Disease Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country
  11. 8.4.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Dementia and Alzheimer’s Disease Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032)
  2. 9.2 China Dementia and Alzheimer’s Disease Treatment Market Size by Type
  3. 9.2.1 China Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Dementia and Alzheimer’s Disease Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Dementia and Alzheimer’s Disease Treatment Market Share by Type (2021-2032)
  6. 9.3 China Dementia and Alzheimer’s Disease Treatment Market Size by Application
  7. 9.3.1 China Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Dementia and Alzheimer’s Disease Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Dementia and Alzheimer’s Disease Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032)
  2. 10.2 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Type
  3. 10.2.1 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Dementia and Alzheimer’s Disease Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Application
  7. 10.3.1 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Dementia and Alzheimer’s Disease Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Country
  11. 10.4.1 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Dementia and Alzheimer’s Disease Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst